Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VHA Purchase Agreements With 15 Device Firms Will Save $167 Annually

This article was originally published in The Gray Sheet

Executive Summary

Fifteen device manufacturers have signed agreements with VHA worth an estimated $760 mil. in annual committed member purchases over the next three years. The agreements, dubbed the Opportunity program, cover 25 selected device categories in cardiac catheterization, orthopedics and anesthesiology. The group purchasing organization estimates that the agreements will save its member organizations $167 mil. while improving participating manufacturers' market shares.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel